Cardiovascular Drugs Market Size Straits Research, a leading provider of business intelligence, research, and advisory services, has released its latest report on the global cardiovascular drugs market, highlighting significant growth opportunities driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in drug development, and expanding healthcare access worldwide. The  global cardiovascular drugs market size  was valued at USD 154.32 billion in 2024 and is projected to reach USD 243.87 billion by 2033, growing at a CAGR of 5.2% during the forecast period. Cardiovascular Drugs Market Catalysts for Expansion The cardiovascular drugs market is expanding rapidly due to several key catalysts. One of the primary drivers is the rising global burden of cardiovascular diseases, including hypertension, coronary artery disease, and heart failure. Sedentary lifestyles, unhealthy diets, smoking, and increasing stress levels are contributing to the growi...